Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Azithromycin: 3-Day Versus 5-Day Couse in the Treatment of Respiratory Tract Infections in Children (CROSBI ID 276123)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Ficnar, B ; Huzjak, N ; Orešković, K ; Matrapazovski, M ; Klinar, I ; Croatian Azithromycin Study Group Azithromycin: 3-Day Versus 5-Day Couse in the Treatment of Respiratory Tract Infections in Children // Journal of chemotherapy, 9 (1997), 1; 38-43

Podaci o odgovornosti

Ficnar, B ; Huzjak, N ; Orešković, K ; Matrapazovski, M ; Klinar, I ; Croatian Azithromycin Study Group

engleski

Azithromycin: 3-Day Versus 5-Day Couse in the Treatment of Respiratory Tract Infections in Children

A total of 371 children, aged 6 months to 12 years, with acute otitis media, acute sinusitis, streptococcal tonsillitis/ pharyngitis, or pneumonia were included in an open, multicenter study. The result of this study demonstrates that 3-day and 5-day azithromycin courses have comparable efficacy and tolerability in children with respiratory infections.

Azihromycin ; sinusitis ; otitis media ; pharyngitis ; tonsillitis ; pneumonia

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

9 (1)

1997.

38-43

objavljeno

1120-009X

1973-9478

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost